pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·18m ago·1 min read
save

What Oura's IPO filing reveals about its healthcare ambitions

Sep 10, 2026·read at Endpoints ↗

Oura's newly filed S-1 sheds some light on how it's thinking about its healthcare business. As it gears up to go public, Oura described in its S-1, released ...

source

Reporting by Endpoints.

read at Endpoints ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1h agoBridgeBio Oncology slides as it tightens the scope of its KRAS programEndpoints
  • 6h agoPharma investment in UK picks up after last year’s lull, trade group saysEndpoints
  • 18h agoEncoded closes $275M Series F for Dravet syndrome drugEndpoints
  • 18h agoARPA-H picks UpDoc, Tempus and Atman to build AI tools for heart diseaseEndpoints
  • 19h agoFDA should follow EMA's lead on drug rejection disclosures, researchers sayEndpoints